Study of BBT002 for chronic sinusitis with nasal polyps and asthma
Treatments studied
Part of Ear, nose & throat, Lungs & breathing clinical trials.
This study tests a new drug called BBT002 in healthy people and in patients with chronic sinusitis and nasal polyps, with or without asthma. It aims to see if the drug is safe and effective for reducing symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 55 years old (for healthy volunteers) or 18 to 75 years old (for patients).
- Your body mass index is between 18 and 30, and you weigh 120 kg or less.
- You have been diagnosed with chronic sinusitis and nasal polyps (for the patient part of the study).
- You have a total score of 30 or more on a sinus symptoms questionnaire (SNOT-22).
- You have needed or been considered for steroid treatment in the past 2 years for your sinusitis.
- If you have asthma, it is stable and you are on regular treatment (GINA Step 3 or higher) for at least 6 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether certain markers in your blood can predict how well biologic injections (medicines that reduce inflammation) will work for chronic sinusitis with nasal polyps. You'll continue your regular nasal spray and may receive a biologic or a placebo (a shot with no medicine) to see if it improves your symptoms.
This study tests an injection called LP-003 that may help reduce nasal polyps and improve breathing. It's for people whose symptoms are not controlled by standard treatments like steroid sprays or surgery.
This trial tests if seeing a lung specialist and an ear-nose-throat doctor together in one visit helps people with asthma and chronic sinusitis (with nasal polyps) feel better than seeing each specialist separately. You may qualify if your asthma or sinusitis is not well-controlled and you've used steroid pills in the past year.
This trial tests an injectable drug called TQC2731 for people with chronic sinusitis and nasal polyps that haven't been controlled well enough by standard treatments like steroid sprays or surgery. The goal is to see if it helps reduce nasal congestion, improve sense of smell, and shrink polyps.
This study looks for certain markers in your blood and nasal tissue that may be linked to chronic sinusitis with nasal polyps. It may help doctors understand the condition better and could lead to more targeted treatments in the future.
This study tests a new medicine called AK139 (given as an injection) to reduce nasal polyps and improve breathing. It is for adults with chronic sinusitis and nasal polyps who still have symptoms despite using steroid sprays.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.